2012

Abdi İbrahim Global Pharm (AİGP) was established by merging pharmaceutical sector leaders and became a pioneering company in Kazakhstan.

Milestone: Among the first Kazakhstani companies to earn the Good Manufacturing Practice (GMP) certification.



2013

AİGP expanded its portfolio to include new molecules and production forms, marking the beginning of its export journey.



2015

The AİGP Production Plant achieved a production capacity of 1.5 billion tablets/capsules annually, setting a regional benchmark.

2018

AİGP strengthened its export footprint, reaching Georgia, Azerbaijan, Afghanistan, Uzbekistan, and Kyrgyzstan while initiating registration processes in Russia, Belarus, and Armenia.



2020

It introduced modern, science-intensive medicinal products, enhancing its retail and public procurement market position.



2021

Increased production efficiency and invested in state-of-the-art laboratory and research facilities, cementing its role as a trusted partner in contract manufacturing.